OncoImmunology · 2020 · 80 citations · 37 references
Life SciencesImmunologyOncologyApoptosisCancer ImmunologyImmunoregulationAntitumor T Cell ResponsesCancer ImmunotherapyCytokines In Tumor ImmunityCytotoxic T Lymphocyte ResponsesT Cell BiologyT Cell Responses To TumorsActivationAdaptive Antitumor ImmunityB7 Family Immunoregulatory LigandsCancer Cell ApoptosisImmune Cell Activation MarkersInnate Antitumor ImmunityT Cell CytotoxicityT Cell-mediated Cytotoxicity
γδT cells were distinctly increased in the peripheral blood and tumor tissues of colon cancer patients. B7-H3 blockade or knockdown promoted proliferation, inhibited cell apoptosis and induced the expression of activation markers (CD25 and CD69) on Vδ2 T cells. In contrast, treatment with the B7-H3 agonist 4H7 had the opposite effect. Furthermore, B7-H3 suppressed IFN-γ expression by inhibiting T-bet in Vδ2 T cells. Moreover, B7-H3 mediated the inhibition of Vδ2 T cell cytotoxicity via the downregulation of IFN-γ and perforin/granzyme B expression. More importantly, blocking the B7-H3 function significantly enhanced the cytotoxicity of Vδ2 T cells against colon cancer cells in vivo. Therefore, the inhibition or blockade of B7-H3 is a potential immunotherapeutic approach for colon cancer.
37
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter, Bruce L. Levine, Michael Kalos et al. · New England Journal of Medicine · 2011 · 3.5K citations · Full text
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Ta-Chung Yu, Fangfang Guo, Yanan Yu et al. · Cell · 2017 · 2.2K citations · Full text
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
Andrei I. Chapoval, Jian Ni, Julie S. Lau et al. · Nature Immunology · 2001 · 1K citations